Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma

Overview of attention for article published in New England Journal of Medicine, October 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 4 public wall posts from 3 users.

Das metastasierende Melanom des Auges ist nun behandelbar geworden. Es entsteht aus Pigmentzellen des Augenhintergrunds und ist…

This 3-year analysis supported a continued long-term benefit of tebentafusp for overall survival among adult HLA-A*02:01–positive…

This 3-year analysis supported a continued long-term benefit of tebentafusp for overall survival among adult HLA-A*02:01–positive…

A hopeful day for #uvealmelanoma especially those with #metastasis Read these three articles respectively below: 3 year…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.